Overview

iNOPulse for COVID-19

Status:
Withdrawn

Trial end date:
2021-07-15

Target enrollment:

Participant gender:

Summary

This randomized, controlled trial will assess the efficacy and safety of pulsed iNO in subjects with COVID-19 who are hospitalized and require supplemental oxygen.

Phase:

Phase 2

Details

Lead Sponsor:

Roger Alvarez

Collaborator:

Bellerophon Therapeutics

Treatments:

Nitric Oxide